Experience

NeuClone

• Australia
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Development Officer

  • Feb 2021 - Present



Drop Bio Health

• Australia
• Biotechnology
• 1 - 100 Employee

• Chief Operating Officer

  • Nov 2019 - Feb 2021



Aurobindo Pharma Ltd

• Hyderabad Area, India

• Vice President - Regulatory Sciences & Clinical Strategy

  • May 2017 - Mar 2019



Intas Pharmaceuticals

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• AVP-Analytical Development and Global Regulatory Affairs

  • Nov 2015 - Feb 2017



Immune System Therapeutics Ltd

• Biotechnology Research
• 1 - 100 Employee

• • 2009 - Jan 2015

  - Development and implementation of scientific research and intellectual property (IP) strategies- Implementation of ISTL’s clinical strategy- Manager and QA representative in a collaborative project with a lead global CMO for cGMP productoin of clinical trial materials- Development and implementation cGMP mode of function and stability studies- Preparation and submission of regulatory packages- Preparation of data packages for inclusion in patent applications- Review and approval of contracts, NDAs, MTAs and other relevant documentations in relation to scientific and clinical collaborative undertakings Show less

• • Aug 2005 - 2009

  - Development of scientific methodologies for in support of ISTL’s research/clinical/IP portfolios- Managing ISTL’s collaborative project with a lead US biotechnology company - Development of protocols for conduct of pre-clinical studies on ISTL’s lead antibody therapeutic in association with multiple CROs- Development of the protocol and other relevant documents, initiation and overseeing of the conduct of a phase I clinical trial in multiple myeloma- Development, qualification and validation of a pharmacokinetic (pK) assay - Development and qualification of an anti-drug antibody (ADA) assay Show less



Intas Pharmaceuticals

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• • 2015 - 2015

• • 2015 - 2015



Immune System Therapeutics Ltd

• Biotechnology Research
• 1 - 100 Employee

• Research Scientist

  • 2002 - 2005

  - Development and implementation of methodologies for production of mouse monoclonal antibodies (mAbs) - Isolation and confirmation of the variable (V) region gene sequence of mAbs - Generation of genetic constructs for production of the chimeric mAbs - Establishment of cell culture methods for laboratory scale production of chimeric mAbs - Development and implementation of scientific projects for characterization mAbs - Development and implementation of methodologies for generation of a humanized mAbs Show less



Center for Thrombosis and Vascular Research

• Sydney, Australia

• Research Scientist

  • 1999 - 2002

  - Development of a system of isolation of antibody genes and their humanization - Development of expression systems (CHO and insect cell) for generation of antibody and antibody fragments - Supervision of honours students - Development and implementation of methodologies for assay of platelets - Development of a system of isolation of antibody genes and their humanization - Development of expression systems (CHO and insect cell) for generation of antibody and antibody fragments - Supervision of honours students - Development and implementation of methodologies for assay of platelets



Centre for thrombosis and vascular research

• Research Scientist

  • 1999 - 2002